PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33006801-4	2021	The macrocyclic polyketide compounds exhibited wide-spectrum of anti-infective potential against clinically significant vancomycin-resistant Enterococcus faecalis (VREfs), methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, and Klebsiella pneumonia with minimum inhibitory concentration of about 1-3 microg mL-1 , insomuch as the antibiotics chloramphenicol and ampicillin were active at >= 6.25 microg mL-1 .	Polyketides	16-26	L1 cell adhesion molecule	Mus musculus	331-335	
33006801-4	2021	The macrocyclic polyketide compounds exhibited wide-spectrum of anti-infective potential against clinically significant vancomycin-resistant Enterococcus faecalis (VREfs), methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, and Klebsiella pneumonia with minimum inhibitory concentration of about 1-3 microg mL-1 , insomuch as the antibiotics chloramphenicol and ampicillin were active at >= 6.25 microg mL-1 .	Polyketides	16-26	L1 cell adhesion molecule	Mus musculus	427-431